Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Bates

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576Manish Agrawal, Jame Abraham, Frank M Balis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
A phase II clinical trial of ixabepilone (Ixempra; BMS-247550; NSC 710428), an epothilone B analog, in patients with metastatic renal cell carcinomaHui Huang, Michael Menefee, Maureen Edgerly, et al.
Cancer Research|August 17, 2005
Depletion of mutant p53 and cytotoxicity of histone deacetylase inhibitorsMikhail V Blagosklonny, Shana Trostel, Ganesh Kayastha, et al.
The Oncologist|April 25, 2021
Prolonged Response to HER2-Directed Therapy in Three Patients with HER2-Amplified Metastatic Carcinoma of the Biliary System: Case Study and Review of the LiteratureMichael May, Alexander G Raufi, Sina Sadeghi, et al.
The Oncologist|May 11, 2025
Correlation between tumor growth rate and survival in patients with metastatic breast cancer treated with trastuzumab deruxtecanPhilip He, Dhiraj Gambhire, Haiming Zhou, et al.
Cancer|April 1, 2005
A Phase I clinical trial of ixabepilone (BMS-247550), an epothilone B analog, administered intravenously on a daily schedule for 3 daysSen H Zhuang, Manish Agrawal, Maureen Edgerly, et al.
Plos One|March 18, 2021
Optimal treatment strategies for stage I non-small cell lung cancer in veterans with pulmonary and cardiac comorbiditiesKeith Sigel, Chung Yin Kong, Sadiq Rehmani, et al.
Cancer Research|February 4, 2016
Effects of Anticancer Drugs on Chromosome Instability and New Clinical Implications for Tumor-Suppressing TherapiesHee-Sheung Lee, Nicholas C O Lee, Natalay Kouprina, et al.
Archives of Dermatological Research|September 11, 2017
Human axillary skin condition is improved following incorporation of glycerol into the stratum corneum from an antiperspirant formulationRichard L Evans, Graham A Turner, Susan Bates, et al.
Developmental Biology|December 31, 2003
Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heartCindy M Martin, Annette P Meeson, Scott M Robertson, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576Manish Agrawal, Jame Abraham, Frank M Balis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
A phase II clinical trial of ixabepilone (Ixempra; BMS-247550; NSC 710428), an epothilone B analog, in patients with metastatic renal cell carcinomaHui Huang, Michael Menefee, Maureen Edgerly, et al.
Cancer Research|August 17, 2005
Depletion of mutant p53 and cytotoxicity of histone deacetylase inhibitorsMikhail V Blagosklonny, Shana Trostel, Ganesh Kayastha, et al.
The Oncologist|April 25, 2021
Prolonged Response to HER2-Directed Therapy in Three Patients with HER2-Amplified Metastatic Carcinoma of the Biliary System: Case Study and Review of the LiteratureMichael May, Alexander G Raufi, Sina Sadeghi, et al.
The Oncologist|May 11, 2025
Correlation between tumor growth rate and survival in patients with metastatic breast cancer treated with trastuzumab deruxtecanPhilip He, Dhiraj Gambhire, Haiming Zhou, et al.
Cancer|April 1, 2005
A Phase I clinical trial of ixabepilone (BMS-247550), an epothilone B analog, administered intravenously on a daily schedule for 3 daysSen H Zhuang, Manish Agrawal, Maureen Edgerly, et al.
Plos One|March 18, 2021
Optimal treatment strategies for stage I non-small cell lung cancer in veterans with pulmonary and cardiac comorbiditiesKeith Sigel, Chung Yin Kong, Sadiq Rehmani, et al.
Cancer Research|February 4, 2016
Effects of Anticancer Drugs on Chromosome Instability and New Clinical Implications for Tumor-Suppressing TherapiesHee-Sheung Lee, Nicholas C O Lee, Natalay Kouprina, et al.
Archives of Dermatological Research|September 11, 2017
Human axillary skin condition is improved following incorporation of glycerol into the stratum corneum from an antiperspirant formulationRichard L Evans, Graham A Turner, Susan Bates, et al.
Developmental Biology|December 31, 2003
Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heartCindy M Martin, Annette P Meeson, Scott M Robertson, et al.
Pageof 4